Mostrar el registro sencillo del ítem

dc.contributor.advisorSuarez Mattos, Amarantospa
dc.contributor.authorMorales-Ramírez, Laura
dc.contributor.authorÁlvarez-Londoño, Angelina
dc.contributor.authorGonzález-Motta, Alejandro
dc.contributor.authorVallejo, María Teresa
dc.contributor.authorCotes-Mestre, Martha
dc.contributor.authorSuárez-Mattos, Amaranto
dc.contributor.otherVallejo, María Teresaspa
dc.coverage.spatialMedicinaspa
dc.date.accessioned2020-06-18T12:14:22Z
dc.date.available2020-06-18T12:14:22Z
dc.date.issued2020-01-27
dc.identifier.urihttp://hdl.handle.net/10654/35932
dc.description.abstractLa supervivencia global de los pacientes pediátricos con cáncer ha mejorado de manera constante en los últimos 40 años; esto se ve reflejado en el aumento de la supervivencia a 5 años, la cual a mediados de los 70 era de un 58% y a principios del 2000 llegó a ser mayor del 80%.1 Esto se debe principalmente a avances en los diferentes esquemas de tratamientos, los cuales han permitido que una gran proporción de pacientes alcancen la adultez. Sin embargo, este aumento en la supervivencia implica una serie de complicaciones a largo plazo, de las cuales el desarrollo de segundas neoplasias es la más preocupante. Se realizó una revisión exploratoria de la literatura siguiendo los lineamientos del manual de PRISMA-ScP para revisiones exploratorias. Se redactó un protocolo inicial siguiendo los lineamientos establecidos en el manual de revisiones sistemáticas del JBI. Debido al tipo de revisión, no fue posible registrar el protocolo en la plataforma PROSPERO. Como resultados del proceso de búsqueda, fueron identificados un total de 7696 artículos revisados. Posterior al proceso de revisión de títulos, resúmenes y criterios de elegibilidad, fueron incluidos 62 artículos, los cuales pertenecían a 18 cohortes de pacientes pediátricos supervivientes de cáncer reclutadas en diferentes países del mundo. Las cohortes abarcan 3 continentes y un total de 15 países. De estas 18 cohortes, 10 provienen de Norte América y 8 pertenecen exclusivamente a Estados Unidos. Al evaluar de forma individual las 6 cohortes que correspondían a registros nacionales se encontró que los 5 tumores secundarios más comunes en cada una de ellas encontramos que las neoplasias de SNC estuvieron dentro de los tumores más frecuentes en 5 de 6 cohortes nacionales, al igual que los tumores de piel, en 4 de 6 cohortes nacionales se encontró al cáncer óseo dentro de los más frecuentes, 3 cohortes reportaron la leucemia dentro de sus neoplasias secundarias más frecuentes, los carcinomas fueron reportados dentro de los más frecuentes en 2 cohortes nacionales al igual que los sarcomas de tejidos blandos , el cáncer de mama y el cáncer de tiroides . Solo la cohorte Alemana reporto los linfomas dentro de sus 5 tumores secundarios más frecuentes. En las 12 cohortes que correspondían a registros institucionales se encontró que el cáncer óseo estuvo dentro de los tumores más frecuentes en 9 de los 12 registros, las neoplasias de SNC se reportaron en 7 de los 12 registros institucionales dentro de los tumores más frecuente, al igual que los tumores de piel y el cáncer de tiroides , las leucemias, los sarcomas de tejidos blandos y el cáncer de mama fueron reportados dentro de los tumores secundarios más comunes en 4 de las 12 cohortes institucionales. Es relevante destacar que este artículo es el primero en recopilar todas las publicaciones disponibles hasta el momento acerca de segundas neoplasias primarias en pacientes pediátricos; agrupando los diferentes artículos disponibles por cohortes encontrando así hallazgos más globales y brindando un punto de partida para desarrollar estudios que identifiquen los posibles factores de riesgo para desarrollar segundas neoplasias y así crear programas de seguimiento en esto pacientes.spa
dc.description.tableofcontentsI. Título II. Resumen III. Introducción IV. Métodos V. Resultados VI. Discusión VII. Bibliografíaspa
dc.formatpdfspa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.language.isospaspa
dc.publisherUniversidad Militar Nueva Granadaspa
dc.rightsDerechos Reservados - Universidad Militar Nueva Granada, 2020spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.5/co/spa
dc.titleSegundos Tumores Primarios En Pacientes Supervivientes de Cáncer en la Edad Pediátrica: Una Revisión Exploratoriaspa
dc.typeinfo:eu-repo/semantics/bachelorThesisspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.publisher.departmentFacultad de Medicinaspa
dc.type.localTrabajo de gradospa
dc.description.abstractenglishThe overall survival of pediatric patients with cancer has steadily improved over the past 40 years; This is reflected in the increase in 5-year survival, which in the mid-1970s was 58% and in the early 2000s it became greater than 80% .1 This is mainly due to advances in the different schemes of treatments, which have allowed a large proportion of patients to reach adulthood. However, this increase in survival implies a series of long-term complications, of which the development of second malignancies is the most worrying. An exploratory review of the literature was carried out following the guidelines of the PRISMA-ScP manual for exploratory reviews. An initial protocol was drafted following the guidelines established in the JBI manual of systematic reviews. Due to the type of review, it was not possible to register the protocol on the PROSPERO platform. As a result of the search process, a total of 7696 articles reviewed were identified. After the review process of titles, summaries and eligibility criteria, 62 articles were included, which belonged to 18 cohorts of pediatric cancer survivors recruited in different countries of the world. Cohorts cover 3 continents and a total of 15 countries. Of these 18 cohorts, 10 come from North America and 8 belong exclusively to the United States. When individually evaluating the 6 cohorts that corresponded to national registries, it was found that the 5 most common secondary tumors in each of them found that CNS neoplasms were among the most frequent tumors in 5 of 6 national cohorts, as well as Skin tumors, in 4 of 6 national cohorts, bone cancer was found within the most frequent, 3 cohorts reported leukemia within their most frequent secondary malignancies, carcinomas were reported within the most frequent in 2 national cohorts. than soft tissue sarcomas, breast cancer and thyroid cancer. Only the German cohort reported lymphomas within its 5 most frequent secondary tumors. In the 12 cohorts that corresponded to institutional registries it was found that bone cancer was among the most frequent tumors in 9 of the 12 registries, CNS neoplasms were reported in 7 of the 12 institutional registries within the most frequent tumors, at Like skin tumors and thyroid cancer, leukemias, soft tissue sarcomas and breast cancer were reported within the most common secondary tumors in 4 of the 12 institutional cohorts. It is relevant to highlight that this article is the first to compile all the publications available so far about second primary malignancies in pediatric patients; grouping the different articles available by cohorts thus finding more global findings and providing a starting point to develop studies that identify the possible risk factors to develop second neoplasms and thus create follow-up programs in this patients.eng
dc.title.translatedSecond Primary Tumors in Pediatric Cancer Surviving Patients: An Scoping Reviewspa
dc.subject.keywordsPediatric cancerspa
dc.subject.keywordssurvivorsspa
dc.subject.keywordssecondary neoplasmsspa
dc.subject.keywordsChemotherapyspa
dc.subject.keywordsRadiotherapyspa
dc.subject.keywordsPrimary tumorsspa
dc.publisher.programOncología Radioterápicaspa
dc.creator.degreenameEspecialista en Oncología Radioterápicaspa
dc.subject.decsNEOPLASMAS EN NIÑOS
dc.subject.decsCANCER
dc.subject.decsENFERMOS DE CANCER-REHABILITACION
dc.description.degreelevelEspecializaciónspa
dc.publisher.facultyMedicina y Ciencias de la Salud - Oncología Radioterápicaspa
dc.type.dcmi-type-vocabularyTextspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadasspa
dc.relation.references1. Eng C, Li Fp, Abramson Dh, Et Al: Mortality From Second Tumors Among Long-Term Survivors Of Retinoblastoma. J Natl Cancer Inst 85:1121-1128,1993spa
dc.relation.references2. Wong Fl, Boice Jd Jr, Abramson Dh, Tarone Re, Kleinerman Ra, Stovall M, Et Al. Cancer Incidence After Retinoblastoma. Radiation Dose And Sarcoma Risk. Jama 1997;278:1262–7spa
dc.relation.references3. Abramson Dh, Frank Cm: Second Nonocular Tumors In Survivors Of Bilateral Retinoblastoma: Apossible Age Effect On Radiation-Related Risk. Oph-Thalmology 105:573-579, 1998; Discussion 579-580spa
dc.relation.references4. Kleinerman Ra, Tucker Ma, Abramson Dh, Et Al: Risk Of Soft Tissue Sarcomas By Individual Subtype In Survivors Of Hereditary Retinoblastoma. J Natl Cancer Inst 99:24-31, 2007spa
dc.relation.references5. Kleinerman Ra, Schonfeld Sj, Tucker Ma:Sarcomas In Hereditary Retinoblastoma. Clin Sarcoma Res 2:15, 2012spa
dc.relation.references6. Jeannette R. Wong, Lindsay M. Morton, Margaret A. Tucker Et Al Risk Of Subsequent Malignant Neoplasms In Long-Term Hereditary Retinoblastoma Survivors After Chemotherapy And Radiotherapy J Clin Oncol 32:3284-3290. © 2014 By American Society Of Clinical Oncologyspa
dc.relation.references7. Lisa B Kenney,Cheryl Medeiros Nancarrow, Julie Najita Et Al Health Status Of The Oldest Adult Survivors Of Cancer During Childhood Cancer January 15, 2010spa
dc.relation.references8. Meadows At, Baum E, Fossati-Bellani F, Et Al. Second Malignant Neoplasms In Children: An Update From The Late Effects Study Group. J Clin Oncol 1985;3(4):532–8.spa
dc.relation.references9. Tucker Ma, Meadows At, Boice Jd, Et Al: Leukemia After Therapy With Alkylating Agents For Child- Hood Cancer. J Natl Cancer Inst 78:459-464, 1987spa
dc.relation.references10. Tucker Ma, Morris Jones Ph, Boice Jd Jr, Robison Ll, Stone Bj, Stovall M, Et Al. Therapeutic Radiation At A Young Age Is Linked To Secondary Thyroid Cancer. The Late Effects Study Group. Cancer Res 1991;/51:/2885 ����� 8.spa
dc.relation.references11. Bhatia S, Sather Hn, Pabustan Ob, Trigg Me, Gaynon Ps, Robison Ll. Low Incidence Of Second Neoplasms Among Children Diagnosed With Acute Lymphoblastic Leukemia After 1983. Blood 2002;99:4257�����64.spa
dc.relation.references12. Li Fp, Cassady Jr, Jaffe N. Risk Of Second Tumors In Survivors Of Childhood Cancer. Cancer 1975;35(4):1230–5.spa
dc.relation.references13. Li Fp, Tucker Ma, Fraumeni Jf Jr. Childhood Cancer In Sibs. J Pediatr 1976; 88: 419–23.spa
dc.relation.references14. Kushner, B.H., Heller, G., Cheung, N.K., Wollner, N., Kramer, K., Bajorin, D., Polyak, T. And Meyers, P.A., High Risk Of Leukemia After Short-Term Dose-Intensive Chemotherapy In Young Patients With Solid Tu- Mors. J. Clin. Oncol., 16, 3016–3020 (1998).spa
dc.relation.references15. Green, D.M., Hyland, A., Barcos, M.P., Reynolds, J.A., Lee, R.J., Hall, B.C. And Zevon, M.A., Second Malignant Neoplasms After Treatment For Hodgkin’s Disease In Childhood Or Adolescence. J. Clin. Oncol., 18, 1492–1499 (2000)spa
dc.relation.references16. Haselow Re, Nesbit M, Dehnen Lp, Khan Fm, Mchugh A, Levitt Sh. Second Neoplasms Following Megavoltage Radiation In A Pediatric Population. Cancer 1978;42: 1,185-1,191spa
dc.relation.references17. Potish, R.A., Dehner, L.P., Haselow, R.E., Kim, T.H., Levitt, S.H. & Nesbit, M. (1985). The Incidence Of Second Neoplasms Following Megavoltage Radiation For Paediatric Tumours. Cancer, 56, 1534.spa
dc.relation.references19. Neglia Jp, Friedman Dl, Yasui Y, Et Al: Second Malignant Neoplasms In Five Year Survivors Of Child- Hood Cancer: Report From The Childhood Cancer Survivor Study. J Natl Cancer Inst 93:618-629, 2001spa
dc.relation.references20. Lisa B. Kenney, Md; Yutaka Yasui, Phd; Peter D. Inskip, Scd; Sue Hammond, Md; Joseph P. Neglia, Md; Ann C. Mertens, Phd; Anna T. Meadows, Md; Debra Friedman, Md; Leslie L. Robison, Phd; And Lisa Diller, Md Breast Cancer After Childhood Cancer: A Report From The Childhood Cancer Survivor Study Ann Intern Med. 2004;141:590-597.spa
dc.relation.references21. Mertens Ac, Mitby Pa, Radloff G, Et Al: Xrcc1 And Glutathione-S-Transferase Gene Polymor- Phisms And Susceptibility To Radiotherapy-Related Malignancies In Survivors Of Hodgkin Disease: A Report From The Childhood Cancer Survivor Study. Cancer 101:1463-1472, 2004spa
dc.relation.references22. Perkins Jl, Liu Y, Mitby Pa, Et Al: Nonmela- Noma Skin Cancer In Survivors Of Childhood And Ado- Lescent Cancer: A Report From The Childhood Cancer Survivor Study. J Clin Oncol 23:3733-3741, 2005spa
dc.relation.references23. Bassal M, Mertens Ac, Taylor L, Et Al: The Risk Of Selected Subsequent Carcinomas In Survivors Of Childhood Cancer: A Report From The Childhood Can- Cer Survivor Study. J Clin Oncol 24:476-483, 2006spa
dc.relation.references24. Sigurdson Aj, Ronckers Cm, Mertens Ac, Et Al: Primary Thyroid Cancer After A First Tumour In Childhood (The Childhood Cancer Survivor Study): A Nested Case-Control Study. Lancet 365:2014-2023, 2005spa
dc.relation.references25. Neglia Jp, Robison Ll, Stovall M, Et Al: New Primary Neoplasms Of The Central Nervous System In Survivors Of Childhood Cancer: A Report From The Childhood Cancer Survivor Study. J Natl Cancer Inst 98:1528-1537, 2006spa
dc.relation.references26. Ronckers Cm, Sigurdson Aj, Stovall M, Et Al: Thyroid Cancer In Childhood Cancer Survivors: A Detailed Evaluation Of Radiation Dose Response And Its Modifiers. Radiat Res 166:618-628, 2006spa
dc.relation.references27. Bluhm Ec, Ronckers C, Hayashi Rj, Et Al: Cause-Specific Mortality And Second Cancer Inci- Dence After Non-Hodgkinlymphoma: A Report From The Childhood Cancer Survivor Study. Blood 111: 4014-4021, 2008spa
dc.relation.references28. Henderson To, Whitton J, Stovall M, Et Al: Secondary Sarcomas In Childhood Cancer Survivors: A Report From The Childhood Cancer Survivor Study. J Natl Cancer Inst 99:300-308, 2007spa
dc.relation.references29. Mulrooney Da, Dover Dc, Li S, Et Al: Twenty Years Follow-Up Among Survivors Of Childhood And Young Adult Acute Myeloid Leukemia: A Report From The Childhood Cancer Survivor Study. Cancer 112: 2071-2079, 2008spa
dc.relation.references30. Meadows At, Friedman Dl, Neglia Jp, Et Al. Second Neoplasms In Survivors Of Childhood Cancer: Findings From The Childhood Cancer Survivor Study Cohort. J Clin Oncol. 2009; 27(14):2356– 2362. [Pubmed: 19255307]spa
dc.relation.references31. Lucie M. Turcotte, John A. Whitton, Debra L. Friedman Et Al Risk Of Subsequent Neoplasms During The Fifth And Sixth Decades Of Life In The Childhood Cancer Survivor Study Cohortspa
dc.relation.references32. Kerri Nottage, Joshua Mcfarlane, Matthew J. Krasin, Chenghong Li Et Al Secondary Colorectal Carcinoma After Childhood Cancer J Clin Oncol 30:2552-2558. © 2012 By American Society Of Clinical Oncologyspa
dc.relation.references33. Amanda M. Termuhlen, M.D.Jean M. Tersak, M.D., Qi Liu, M. Sc Et Al Twenty-Five Year Follow-Up Of Childhood Wilms Tumor: A Report From The Childhood Cancer Survivor Study Pediatr Blood Cancer. 2011 December 15; 57(7): 1210–1216. Doi:10.1002/Pbc.23090.spa
dc.relation.references34. Leslie L. Robison, Gregory T. Armstrong, John D. Boice, Eric J. Chow Et Al The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource For Outcome And Intervention Research J Clin Oncol 27:2308-2318. © 2009 By American Society Of Clinical Oncologyspa
dc.relation.references35. Qi Liu, Wendy M. Leisenring, Kirsten K. Ness, Leslie L. Robison, Gregory T. Armstrong, Yutaka Yasui, And Smita Bhatia Racial/Ethnic Differences In Adverse Outcomes Amongchildhood Cancer Survivors: The Childhood Cancer Survivor Study J Clin Oncol 34:1634-1643. © 2016 By American Society Of Clinical Oncologyspa
dc.relation.references36. Macarthur Ac, Spinelli Jj, Rogers Pc, Goddard Kj, Phillips N, Mcbride Ml. Risk Of A Second Malignant Neoplasm Among 5- Year Survivors Of Cancer In Childhood And Adolescence In British Columbia, Canada. Pediatr Blood Cancer 2007spa
dc.relation.references37. Hawkins Mm, Draper Gj, Kingston Je. Incidence Of Second Primary Tumours Among Childhood Cancer Survivors. Br J Cancer 1987;56(3):339–47.spa
dc.relation.references38. Hawkins M M Second Primary Tumors Following Radiotherapy For Childhood Cancer Inl. J Rodumon Oncolo~v RIOI Phyr Vol. 19, pp. 1291- I301spa
dc.relation.references39. Hawkins, M.M., Wilson, L.M., Stovall, M.A., Marsden, H.B., Potok, M.H., Kingston, J.E. And Chessells, J.M., Epipodophyllotoxins, Alkylat- Ing Agents, And Radiation And Risk Of Secondary Leukaemia After Childhood Cancer. Brit. Med. J., 304, 951–958 (1992).spa
dc.relation.references40. Hawkins Mm, Stevens Mc. The Long-Term Survivors. Br Med Bull 1996;52(4):898–923.spa
dc.relation.references41. Hawkins Mm, Lancashire Er, Winter Dl, Et Al: The British Childhood Cancer Survivor Study: Objectives, Methods, Population Structure, Response Rates And Initial Descriptive Information. Pediatr Blood Cancer 50:1018-1025, 2008spa
dc.relation.references42. Jenkinson Hc, Hawkins Mm, Stiller Ca, Winter Dl, Marsden Mc, Stevens Mc. Long-Term Population-Based Risks Of Second Malignant Neoplasms After Childhood Cancer In Britain. Br J Cancer 2004;91(11):1905–10.spa
dc.relation.references43. Aliki J. Taylor, Mark P. Little, David L. Winter, Elaine Sugden, David W. Ellison, Charles A. Stiller, Marilyn Stovall, Clare Frobisher, Emma R. Lancashire, Raoul C. Reulen, And Michael M. Hawkins Population-Based Risks Of Cns Tumors In Survivors Ofchildhood Cancer: The British Childhood Cancer Survivor Study J Clin Oncol 28:5287-5293. © 2010 By American Society Of Clinical Oncologyspa
dc.relation.references44. De Vathaire F, Francois P, Hill C, Schweisguth O, Rodary C, Sarrazin D, Et Al. Role Of Radiotherapy And Chemotherapy In The Risk Of Second Malignant Neoplasms After Cancer In Childhood. Br J Cancer 1989;/59:/792 ����� 6.spa
dc.relation.references45. De Vathaire F, Hawkins M, Campbell S, Et Al. Second Malignant Neoplasms After A First Cancer In Childhood: Temporal Pattern Of Risk According To Type Of Treatment. Br J Cancer 1999;79(11–12):1884–93.spa
dc.relation.references46. Nadia Haddy, Marie Ce ́cile Le Deley, Akhtar Samand Role Of Radiotherapy And Chemotherapy In The Risk Of Secondary Leukaemia After A Solid Tumour In Childhood European Journal Of Cancer 42 (2006) 2757–2764spa
dc.relation.references47. Nygaard R, Garwicz S, Haldorsen T, Hertz H, Jonmundsson Gk, Lanning M, Et Al. Second Malignant Neoplasms In Patients Treated For Childhood Leukemia: A Population-Based Cohort Study From The Nordic Countries.Actapaediatrscand1991;80:1220-8.spa
dc.relation.references48. Olsen Jh, Garwicz S, Hertz H, Et Al: Second Malignant Neoplasms After Cancer In Child- Hood Or Adolescence: Nordic Society Of Paediatric Haematology And Oncology Association Of The Nordic Cancer Registries. Bmj 307:1030-1036, 1993spa
dc.relation.references49. Sankila, R., Garwicz, S., Olsen, J.H., Do ̈llner, H., Hertz, H., Kreuger, A., Langmark, F., Lanning, M., Mo ̈ller, T. And Tulinius, H., Risk Of Subsequent Malignant Neoplasms Among 1,641 Hodgkin’s Disease Patients Diagnosed In Childhood And Adolescence: A Population-Based Cohort Study In The Five Nordic Countries. J. Clin. Oncol., 14, 1442–1446 (1996)spa
dc.relation.references50. Garwicz S, Anderson H, Olsen Jh, Et Al: Second Malignant Neoplasms After Cancer In Child- Hood And Adolescence: A Population-Based Case- Control Study In The 5 Nordic Countries—The Nordic Society For Pediatric Hematology And Oncology. The Association Of The Nordic Cancer Registries. Int J Cancer 88:672-678, 2000spa
dc.relation.references51. Gudrun Svahn-Tapper, Stanislaw Garwicz, Harald Andersonet Al Radiation Dose And Relapse Are Predictors For Development Of Second Malignant Solid Tumors After Cancer In Childhood And Adolescence: A Population-Based Case-Control Study In The Five Nordic Countries Acta Oncologica, 2006; 45: 438-448spa
dc.relation.references52. Olsen Jh, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, Winther Jf, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S. Lifelong Cancer Incidence In 47,697 Patients Treated For Childhood Cancer In The Nordic Countries.J Natl Cancer Inst. 2009; 101:806–813.spa
dc.relation.references53. Cardous-Ubbink Mc, Heinen Rc, Bakker Pj, Et Al. Risk Of Second Malignancies In Long-Term Survivors Of Childhood Cancer. Eur J Cancer 2007;43:351–62.spa
dc.relation.references54. Derkinderen Dj, Koten Jw, Wolterbeek R, Et Al: Non-Ocular Cancer In Hereditary Retinoblastoma Survivors And Relatives. Ophthalmic Paediatr Genet 8:23-25, 1987spa
dc.relation.references55. Moll Ac, Imhof Sm, Schouten-Van Meeteren Ay, Et Al: Second Primary Tumors In Hereditaryretinoblastoma: A Register-Based Study, 1945-1997—Is There An Age Effect On Radiation-Relatedrisk? Ophthalmology 108:1109-1114, 2001spa
dc.relation.references56. Marees T, Moll Ac, Imhof Sm, Et Al: Risk Of Second Malignancies In Survivors Of Retinoblastoma: More Than 40 Years Of Follow-Up. J Natl Cancer Inst 100:1771-1779, 2008spa
dc.relation.references57. Kaatsch P Haaf G Michaelis J Childhood Malignancies In Germany—Methods And Results Of A Nationwide Registry.Eur J Cancer.31a1995993spa
dc.relation.references58. Westermeier T Kaatsch P Schoetzau A Michaelis J Multiple Primary Neoplasms In Childhood: The Data From The German Children's Cancer Registry.Eur J Cancer.341998687spa
dc.relation.references59. Kollmannsberger C, Hartmann Jt, Kanz L, Bokemeyer C. Therapy-Related Malignancies Following Treatment Of Germ Cell Cancer. Int J Cancer. 1999 Dec 10;83(6):860-3.spa
dc.relation.references60. Lo ̈ning, L., Zimmermann, M., Reiter, A., Kaatsch, P., Henze, G., Riehm, H. And Schrappe, M., Secondary Neoplasms Subsequent To Berlin-Frank- Furt-Munster Therapy Of Acute Lymphoblastic Leukemia In Childhood: Sig- Nificantly Lower Risk Without Cranial Radiotherapy. Blood, 95, 2770–2775 (2000).spa
dc.relation.references61. Gkleinajmichaelisacspixarwibbingageggersbjrittercpkaatscha, Second Malignant Neoplasms After Treatment Of Childhood Cancer European Journal Of Cancer Volume 39, Issue 6, April 2003, Pages 808-817spa
dc.relation.references62. Yasushi Ishida, Dongmei Qiu, Miho Maeda Secondary Cancers After A Childhood Cancer Diagnosis: A Nationwide Hospital‐Based Retrospective Cohort Study In Japan Int J Clin Oncol Doi 10.1007/S10147-015-0927-Zspa
dc.subject.proposalCáncer pediátricospa
dc.subject.proposalSupervivientesspa
dc.subject.proposalSegundos primariosspa
dc.subject.proposalQuimioterapiaspa
dc.subject.proposalRadioterapiaspa
dc.subject.proposalTumores primariosspa


Archivos en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Derechos Reservados - Universidad Militar Nueva Granada, 2020
Excepto si se señala otra cosa, la licencia del ítem se describe como Derechos Reservados - Universidad Militar Nueva Granada, 2020